Cargando…
Delivery of Theranostic Nanoparticles to Various Cancers by Means of Integrin-Binding Peptides
Active targeting of tumors is believed to be the key to efficient cancer therapy and accurate, early-stage diagnostics. Active targeting implies minimized off-targeting and associated cytotoxicity towards healthy tissue. One way to acquire active targeting is to employ conjugates of therapeutic agen...
Autores principales: | Egorova, Elena A., Nikitin, Maxim P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696485/ https://www.ncbi.nlm.nih.gov/pubmed/36430214 http://dx.doi.org/10.3390/ijms232213735 |
Ejemplares similares
-
Theranostics Aspects of Various Nanoparticles in Veterinary Medicine
por: Bai, Ding-Ping, et al.
Publicado: (2018) -
Peptide-Based Nanoparticles for αvβ3 Integrin-Targeted DNA Delivery to Cancer and Uterine Leiomyoma Cells
por: Egorova, Anna, et al.
Publicado: (2022) -
Cyclodextrin Based Nanoparticles for Drug Delivery and Theranostics
por: Gadade, Dipak Dilip, et al.
Publicado: (2020) -
Magnetic nanoparticles in theranostics of malignant melanoma
por: Shevtsov, Maxim, et al.
Publicado: (2021) -
Supramolecular lipid nanoparticles as delivery carriers for non-invasive cancer theranostics
por: Bukhari, Syeda Zunaira, et al.
Publicado: (2021)